Study confirms effectiveness of ArtemiC on human immune cell
Filed with ASX · · 6 pages · English
Story so far
Earlier from Argent Biopharma
- Trading halt
- June Quarterly Activity and Cashflow Report
- Reinstatement to Official Quotation
- Suspension from Official Quotation
- MGC Pharma to acquire 100% of Medicinal Cannabis Clinic
Later from Argent Biopharma
- UK distribution agreement signed for MGC Pharma medicines
- COVID-19 Interim Trial Results Meet All Primary Objectives
- JV to be established for registration of ArtemiC in Russia
- Appendix 4E and Preliminary Unaudited Financial Report
- $15M finance facility to fund revenue growth for key markets
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma